CARCINOMA, HEPATOCELLULAR
Clinical trials for CARCINOMA, HEPATOCELLULAR explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, HEPATOCELLULAR trials appear
Sign up with your email to follow new studies for CARCINOMA, HEPATOCELLULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo may keep liver cancer at bay after transplant
Disease control ENROLLING_BY_INVITATIONThis study looks at whether a drug called everolimus can help prevent liver cancer from coming back after a liver transplant. About 336 adults with high-risk liver cancer will receive either everolimus plus tacrolimus or standard drugs. The main goal is to see how long patients l…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE4 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated May 26, 2026 06:09 UTC
-
New hope for kids with liver cancer: personalized therapy trial shows promise
Disease control OngoingThis study is for children with hepatoblastoma or hepatocellular carcinoma, two types of liver cancer. It uses a risk-adapted approach, meaning treatment is tailored to each child's specific situation. The main goal is to see how long children can live without the cancer coming b…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 26, 2026 06:05 UTC
-
New combo therapy targets Hard-to-Treat cancers
Disease control OngoingThis study tests a new drug called E7386 combined with other anticancer drugs in people with advanced solid tumors, including endometrial, liver, and colorectal cancers. The goal is to find safe and effective doses and see if the combination can shrink tumors. About 300 participa…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE1, PHASE2 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated May 26, 2026 06:05 UTC
-
New drug combo shows promise for tough liver cancer
Disease control OngoingThis study tests a combination of two drugs (atezolizumab and bevacizumab) in people with advanced liver cancer who also have chronic hepatitis B. The goal is to see if the treatment can shrink or control the cancer. Participants receive the drugs by IV and are monitored for side…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: NA • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
New drug combo aims to stop liver cancer recurrence after surgery
Disease control OngoingThis study tests whether a combination of two drugs (atezolizumab and bevacizumab) can prevent liver cancer from returning in people who have had surgery or ablation to remove their tumor. About 668 participants at high risk of recurrence will receive either the drug combination …
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New blood test could spot liver cancer sooner in High-Risk patients
Diagnosis ENROLLING_BY_INVITATIONThis study is testing whether a new blood test, called the GAAD score, can improve the detection of liver cancer in people who are at high risk, such as those with cirrhosis or chronic hepatitis. Around 2,100 participants will get an ultrasound and the GAAD blood test every six m…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: NA • Sponsor: Siriraj Hospital • Aim: Diagnosis
Last updated May 18, 2026 11:59 UTC